3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Drug NewsPublic Health


Prevnar trial results needed for CDC recommendation

Drug News • • Public HealthFeb 23 12

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc’s Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults aged 50 and older.

The trial results, expected next year, along with data on whether use of the vaccine in children is affecting rates of disease in adults, will be assessed before a recommendation is made, said CDC spokeswoman Alison Patti.

The Food and Drug Administration in December approved use of Prevnar 13 in older adults and Pfizer said it still expects to begin a marketing campaign in March.

- Full Story - »»»    

Page 1 of 1 pages


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site